Alzamend Neuro Inc (ALZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
(Values in U.S. thousands)
| 10-2025 | 07-2025 | 04-2025 | 01-2025 | 10-2024 | |
| Operating Expenses | 998 | 2,700 | 1,139 | 1,037 | 1,358 |
| Operating Income | -998 | -2,700 | -1,139 | -1,037 | -1,358 |
| Interest Expense | 3 | 3 | 1 | 2 | 4 |
| Pre-tax Income | -1,001 | -2,703 | -1,139 | -1,039 | -1,362 |
| Net Income Continuous | -1,001 | -2,703 | -1,139 | -1,039 | -1,362 |
| Net Income | $-1,001 | $-2,703 | $-1,139 | $-1,039 | $-1,362 |
| EPS Basic Total Ops | -0.30 | -1.28 | 5.42 | -1.71 | -3.61 |
| EPS Basic Continuous Ops | -0.30 | -1.28 | 6.57 | -1.70 | -3.47 |
| EPS Diluted Total Ops | -0.30 | -1.28 | 5.42 | -1.71 | -3.61 |
| EPS Diluted Continuous Ops | -0.30 | -1.28 | 6.57 | -1.70 | -3.47 |
| EPS Diluted Before Non-Recurring Items | -0.30 | -1.28 | N/A | -1.71 | -3.60 |
| EBITDA(a) | $-970 | $-2,673 | $-1,126 | $-1,025 | $-1,345 |